OAC
NAUT icon

OMERS Administration Corp’s Nautilus Biotechnolgy NAUT Stock Holding History

OMERS Administration Corp’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,500
Closed -$95.1K – 1061
2026
Q1 		$95.1K Sell
24,500
-80,285
-77% -$197K ﹤0.01% 1023
2025
Q4 		$204K Buy
+104,785
New +$172K ﹤0.01% 911

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

OMERS Administration Corp's NAUT Position: Q2 2026 in Review

OMERS Administration Corp sold out of Nautilus Biotechnolgy (NAUT) in Q2 2026, closing a stake of 24,500 shares — an estimated $95.1K sold.

OMERS Administration Corp first reported a position in NAUT in Q4 2025 and held it in 2 quarters. The position peaked at $204K in Q4 2025. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • OMERS Administration Corp reported no remaining Nautilus Biotechnolgy position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 24,500 Nautilus Biotechnolgy shares in Q2 2026, an estimated $95.1K.
  • OMERS Administration Corp first reported a position in Nautilus Biotechnolgy in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Nautilus Biotechnolgy position peaked at $204K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.